Abstract
BackgroundDisease relapse can occur in psoriatic arthritis (PsA) when tumour necrosis factor inhibitor (TNFi) therapy is withdrawn. Dose reduction of TNFi whilst maintaining disease control may be possible.ObjectivesTo determine feasibility...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have